HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1992
1301	1301 KAHAN BD, GIBBONSSTUBBER S, TEJPAL N, CHOU TC PROSPECTS FOR SYNERGISTIC IMMUNOSUPPRESSIVE DRUG-THERAPY IN THE COMING DECADE TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1263-1265	0	7	3	23
1302	1302 ONA ET EARLY PITFALLS IN RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1280-1282	0	5	1	19
1303	1303 YAMADA K, SUGISAKI Y, AKIMOTO M, YAMANAKA N FK-506-INDUCED JUXTAGLOMERULAR APPARATUS HYPERPLASIA AND TUBULAR DAMAGE IN RAT KIDNEY-MORPHOLOGICAL AND BIOLOGIC ANALYSIS TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1396-1398	4	8	1	14
1304	1304 FUKUSE T, HASEGAWA S, HIRAI T, HIRATA T, MURO K, et al. OPTIMAL DOSE OF FK-506 IN CANINE LUNG ALLOTRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1399-1400	0	6	2	9
1305	1305 KENMOCHI T, ASANO T, SHIMADA H, OCHIAI T, ISONO K CLINICAL AND EXPERIMENTAL STUDIES OF ACUTE-PANCREATITIS AFTER RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1578-1580	2	10	3	6
1306	1306 TODO S, Tzakis AG, ABUELMAGD K, REYES J, NAKAMURA K, et al. INTESTINAL TRANSPLANTATION IN COMPOSITE VISCERAL GRAFTS OR ALONE ANNALS OF SURGERY. 1992 SEP; 216 (3): 223-234	41	233	4	35
1307	1307 IWATSUKI S, STARZL TE LIVER-TRANSPLANTATION IN THE MANAGEMENT OF BLEEDING ESOPHAGEAL-VARICES BAILLIERES CLINICAL GASTROENTEROLOGY. 1992 SEP; 6 (3): 517-525	0	7	4	37
1308	1308 SATTLER M, GUENGERICH FP, YUN CH, CHRISTIANS U, SEWING KF CYTOCHROME-P-450 3A ENZYMES ARE RESPONSIBLE FOR BIOTRANSFORMATION OF FK506 AND RAPAMYCIN IN MAN AND RAT DRUG METABOLISM AND DISPOSITION. 1992 SEP-OCT; 20 (5): 753-761	23	299	5	48
1309	1309 MARSH JW, VEHE KL, WHITE HM IMMUNOSUPPRESSANTS GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1992 SEP; 21 (3): 679-693	0	10	7	105
1310	1310 EKSTRAND A, GROOP L, PETTERSSON E, GRONHAGENRISKA C, LAATIKAINEN L, et al. METABOLIC CONTROL AND PROGRESSION OF COMPLICATIONS IN INSULIN-DEPENDENT DIABETIC-PATIENTS AFTER KIDNEY- TRANSPLANTATION JOURNAL OF INTERNAL MEDICINE. 1992 SEP; 232 (3): 253-261	0	11	2	22
#	Date / Author / Journal	LCS	GCS	LCR	CR
1311	1311 SINCLAIR NRS LOW-DOSE STEROID-THERAPY IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS WITH WELL-FUNCTIONING GRAFTS CANADIAN MEDICAL ASSOCIATION JOURNAL. 1992 SEP 1; 147 (5): 645-657	17	162	6	61
1312	1312 HOCKERSTEDT K LIVER-TRANSPLANTATION - PRESENT RESULTS AND PROBLEMS ANNALS OF MEDICINE. 1992 OCT; 24 (5): 325-328	0	2	2	24
1313	1313 REVILLARD JP FROM ALLOGRAFTS TO XENOGRAFTS BIOFUTUR. 1992 OCT; (116): 58-61	0	0	3	22
1314	1314 CHRISTIANS U, BRAUN F, SCHMIDT M, KOSIAN N, SCHIEBEL HM, et al. SPECIFIC AND SENSITIVE MEASUREMENT OF FK506 AND ITS METABOLITES IN BLOOD AND URINE OF LIVER-GRAFT RECIPIENTS CLINICAL CHEMISTRY. 1992 OCT; 38 (10): 2025-2032	17	60	4	29
1315	1315 LUO HY, CHEN HF, DALOZE P, WU JP EFFECTS OF RAPAMYCIN ON HUMAN HLA-UNRESTRICTED CELL KILLING CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1992 OCT; 65 (1): 60-64	0	21	3	29
1316	1316 HANKE JH, NICHOLS LN, COON ME FK506 AND RAPAMYCIN SELECTIVELY ENHANCE DEGRADATION OF IL-2 AND GM-CSF MESSENGER-RNA LYMPHOKINE AND CYTOKINE RESEARCH. 1992 OCT; 11 (5): 221-231	2	19	2	53
1317	1317 ERICZON BG, WIJNEN RMH, KUBOTA K, KOOTSTRA G, GROTH CG FK506-INDUCED IMPAIRMENT OF GLUCOSE-METABOLISM IN THE PRIMATE - STUDIES IN PANCREATIC TRANSPLANT RECIPIENTS AND IN NONTRANSPLANTED ANIMALS TRANSPLANTATION. 1992 OCT; 54 (4): 615-620	8	27	9	45
1318	1318 BASRI N, AMAN H, ADIKU W, BARAQDAR A, BONATERO I, et al. DIABETES-MELLITUS AFTER RENAL-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1992 OCT; 24 (5): 1780-1781	2	9	4	13
1319	1319 STARZL TE, DEMETRIS AJ, TRUCCO M, RAMOS H, ZEEVI A, et al. SYSTEMIC CHIMERISM IN HUMAN FEMALE RECIPIENTS OF MALE LIVERS LANCET. 1992 OCT 10; 340 (8824): 876-877	175	277	1	8
1320	1320 JAFFE IA NEW APPROACHES TO THE MANAGEMENT OF RHEUMATOID-ARTHRITIS JOURNAL OF RHEUMATOLOGY. 1992 NOV; 19: 2-8	0	11	3	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
1321	1321 BENIGNI A, MORIGI M, PERICO N, ZOJA C, AMUCHASTEGUI CS, et al. THE ACUTE EFFECT OF FK506 AND CYCLOSPORINE ON ENDOTHELIAL-CELL FUNCTION AND RENAL VASCULAR-RESISTANCE TRANSPLANTATION. 1992 NOV; 54 (5): 775-780	6	73	5	44
1322	1322 MOR E, GONWA TA, HUSBERG BS, GOLDSTEIN RM, KLINTMALM GB LATE-ONSET ACUTE REJECTION IN ORTHOTOPIC LIVER-TRANSPLANTATION - ASSOCIATED RISK-FACTORS AND OUTCOME TRANSPLANTATION. 1992 NOV; 54 (5): 821-824	8	55	2	16
1323	1323 HIRANO Y, HISATOMI A, OHARA K, NOGUCHI H THE EFFECTS OF FK506 AND CYCLOSPORINE ON THE EXOCRINE FUNCTION OF THE RAT PANCREAS TRANSPLANTATION. 1992 NOV; 54 (5): 883-887	3	14	6	33
1324	1324 BOWMAN H, LENNARD TWJ IMMUNOSUPPRESSIVE DRUGS BRITISH JOURNAL OF HOSPITAL MEDICINE. 1992 NOV 4; 48 (9): 570-&	0	1	4	39
1325	1325 RADZICKA A, ACHESON SA, WOLFENDEN R CIS-TRANSISOMERIZATION AT PROLINE - DESOLVATION AND ITS CONSEQUENCES FOR PROTEIN FOLDING BIOORGANIC CHEMISTRY. 1992 DEC; 20 (4): 382-386	0	31	2	30
1326	1326 DEPAULIS A, STELLATO C, CIRILLO R, CICCARELLI A, ORIENTE A, et al. ANTIINFLAMMATORY EFFECT OF FK-506 ON HUMAN SKIN MAST-CELLS JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1992 DEC; 99 (6): 723-728	8	80	8	48
1327	1327 ODELL JA, BRINK JG, ROBSON S, TERBLANCHE J, KAHN D TRANSPLANTATION OF SOLID ORGANS IN SOUTH-AFRICA SOUTH AFRICAN MEDICAL JOURNAL. 1992 DEC; 82 (6): 427-431	0	1	3	67
1328	1328 PROPPER DJ, WOO J, MACLEOD AM, CATTO GRD, THOMSON AW THE EFFECTS OF RAPAMYCIN ON HUMORAL IMMUNITY INVIVO - SUPPRESSION OF PRIMARY RESPONSES BUT NOT OF ONGOING ALLOANTIBODY SYNTHESIS OR MEMORY RESPONSES TRANSPLANTATION. 1992 DEC; 54 (6): 1058-1063	2	10	4	27
1329	1329 SOUZA ERM, BOIM MA, BERGAMASCHI C, VERSOLATO C, PESTANA JOM, et al. ACUTE EFFECTS OF FK-506 ON GLOMERULAR HEMODYNAMICS TRANSPLANTATION PROCEEDINGS. 1992 DEC; 24 (6): 3082-3082	0	1	1	7
1993
1330	1330 SCHULER W, CHRISTIANS U, SCHMIEDER P, SCHIEBEL HM, HOLZE I, et al. STRUCTURAL INVESTIGATIONS OF 13-O-DEMETHYL-FK506 AND ITS ISOMERS GENERATED BY IN-VITRO METABOLISM OF FK506 USING HUMAN-LIVER MICROSOMES HELVETICA CHIMICA ACTA. 1993; 76 (6): 2288-2302	2	11	6	35
#	Date / Author / Journal	LCS	GCS	LCR	CR
1331	1331 THOMSON AW, PROPPER DJ, WOO J, WHITING PH, MILTON JI, et al. COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1993; 15 (4): 355-369	0	13	5	26
1332	1332 TAKAHARA S EFFICACY OF FK506 IN RENAL-TRANSPLANTATION IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 235-244	0	6	2	6
1333	1333 LEMSTER B, RILO HR, CARROLL PB, NALESNIK MA, THOMSON AW FK-506 INHIBITS CYTOKINE GENE AND ADHESION MOLECULE EXPRESSION IN PSORIATIC SKIN-LESIONS IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 250-256	2	8	2	20
1334	1334 TAMURA K, WOO J, MURASE N, NALESNIK M, THOMSON AW INHIBITORY EFFECT OF FK-506 ON AUTOIMMUNE THYROID-DISEASE IN THE PVG RAT IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 257-262	0	0	1	15
1335	1335 OCHIAI T, GUNJI Y, NAGATA M, ISONO K COMBINATION OF IMMUNOSUPPRESSIVE DRUGS FOR ORGAN-TRANSPLANTATION IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 270-280	0	6	3	23
1336	1336 OLAUSSON M, WRAMNER L, KJELLSON B, MJORNSTEDT L, SODERSTROM T ALTERATION IN T-CELL SUBSET PHENOTYPES AS CELL MARKERS FOR REJECTION OR LONG-TERM ALLOGRAFT ACCEPTANCE IN ALLOGRAFTED RATS TREATED WITH ANTITHYMOCYTE GLOBULIN INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 1993; 101 (4): 431-436	0	10	1	20
1337	1337 CHRISTIANS U, SEWING KF CYCLOSPORINE METABOLISM IN TRANSPLANT PATIENTS PHARMACOLOGY & THERAPEUTICS. 1993; 57 (2-3): 291-345	2	114	12	331
1338	1338 JIANG H, YAMAMOTO S, NISHIKAWA K, KATO R ANTI-TUMOR-PROMOTING ACTION OF FK506, A POTENT IMMUNOSUPPRESSIVE AGENT CARCINOGENESIS. 1993 JAN; 14 (1): 67-71	2	34	5	43
1339	1339 HIRAI T, WADDELL TK, PUSKAS JD, WADA H, HITOMI S, et al. PROLONGED LUNG ALLOGRAFT SURVIVAL WITH A SHORT COURSE OF FK-506 JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1993 JAN; 105 (1): 1-8	2	5	7	35
1340	1340 ZENG YJ, RICORDI C, LENDOIRE J, CARROLL PB, ALEJANDRO R, et al. THE EFFECT OF PREDNISONE ON PANCREATIC-ISLET AUTOGRAFTS IN DOGS SURGERY. 1993 JAN; 113 (1): 98-102	1	27	4	27
#	Date / Author / Journal	LCS	GCS	LCR	CR
1341	1341 WAKUGAMI T, ISLAM MR, HIGA S, MURAKAMI K, MIMURA G EFFECT OF FK506 ON THE DEVELOPMENT OF DIABETES IN BB RATS IN COMPARISON WITH THAT OF CYCLOSPORINE TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE. 1993 JAN; 169 (1): 21-29	0	2	2	17
1342	1342 STARZL TE, Fung JJ, Tzakis AG, TODO S, DEMETRIS AJ, et al. BABOON-TO-HUMAN LIVER-TRANSPLANTATION LANCET. 1993 JAN 9; 341 (8837): 65-71	32	296	3	29
1343	1343 BRUSERUD O, PAWELEC G CYCLOSPORINE-A AND FK506 SHOW SIMILAR IMMUNOSUPPRESSIVE EFFECTS ON LONG-TERM INVITRO T-CELL PROLIFERATION INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. 1993 FEB; 15 (2): 93-97	1	3	4	12
1344	1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al. EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 FEB; 55 (2): 288-292	13	53	10	19
1345	1345 CERRA FB USE OF GREENFIELD FILTERS IN RENAL-TRANSPLANT PATIENTS - ARE THEY SAFE TRANSPLANTATION. 1993 FEB; 55 (2): 439-442	0	0	4	24
1346	1346 STARZL TE CONVOCATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 1-2	0	0	2	20
1347	1347 STARZL TE CELL-MIGRATION AND CHIMERISM - A UNIFYING CONCEPT IN TRANSPLANTATION - WITH PARTICULAR REFERENCE TO HLA MATCHING AND TOLERANCE INDUCTION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 8-12	26	41	2	27
1348	1348 STARZL TE LIVER ALLOTRANSPLANTATION AND XENOTRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 15-17	1	13	4	18
1349	1349 RAPAPORT FT ALTERNATIVE SOURCES OF CLINICALLY TRANSPLANTABLE VITAL ORGANS TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 42-44	0	4	1	34
1350	1350 SRIWATANAWONGSA V, DAVIES HS, BRONS IGM, ASPINALL R, THIRU S, et al. CONTINUED PRESENCE OF DONOR LEUKOCYTES IN RECIPIENTS OF LIVER GRAFTS TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 371-372	10	14	1	6
#	Date / Author / Journal	LCS	GCS	LCR	CR
1351	1351 MURASE N, DEMETRIS AJ, TANABE M, MIYAZAWA H, VALDIVIA LA, et al. EFFECT OF FK-506 AND ANTIPROLIFERATIVE AGENTS FOR HEART AND LIVER XENOTRANSPLANTATION FROM HAMSTER TO RAT TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 425-426	1	9	1	8
1352	1352 STARZL TE, MURASE N, DEMETRIS AJ, GIORDA R, VALDIVIA L, et al. DRUG DEVELOPMENT AND TESTING IN RELATION TO CELL-MIGRATION AND CHIMERISM TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 469-472	8	12	5	12
1353	1353 LANG P, BIERLING P, BUISSON C, FRUCHAUD G, BUSSON M, et al. INFLUENCE OF POSTTRANSPLANTATION BLOOD-TRANSFUSION ON KIDNEY ALLOGRAFT SURVIVAL - A ONE-CENTER, DOUBLE- BLIND, PROSPECTIVE, RANDOMIZED STUDY COMPARING CRYOPRESERVED AND FRESH RED-BLOOD-CELL CONCENTRATES TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 616-618	0	5	1	18
1354	1354 GIBBS JF, HUSBERG BS, KLINTMALM GB, BACKMAN L, LEVY M, et al. OUTCOME ANALYSIS OF FK-506 THERAPY FOR ACUTE AND CHRONIC REJECTION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 622-623	1	9	3	7
1355	1355 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al. USE OF FK-506 FOR THE PREVENTION OF RECURRENT ALLOGRAFT-REJECTION AFTER SUCCESSFUL CONVERSION FROM CYCLOSPORINE FOR REFRACTORY REJECTION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 635-637	6	10	5	13
1356	1356 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al. PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 641-643	3	8	6	11
1357	1357 LANE BC, MILLER LN, KAWAI M, OR YS, WIEDEMAN P, et al. EVALUATION OF CALCINEURIN ROLE IN THE IMMUNOSUPPRESSIVE ACTIVITY OF FK-506, RELATED MACROLACTAMS, AND CYCLOSPORINE TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 644-646	3	9	1	17
1358	1358 KUROKI H, BEAN MA, IKUTA Y, AKIYAMA M, BURGESS EM EFFECT OF FK-506 AND DONOR-SPECIFIC BLOOD-TRANSFUSION ON THE RAT COMPOSITE TISSUE LIMB ALLOGRAFT AND THE MECHANISM OF LONG-TERM GRAFT-SURVIVAL TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 658-661	0	9	2	15
1359	1359 TABASCOMINGUILLAN J, MIELES L, CARROLL P, GAVALER J, VANTHIEL DH, et al. LONG-TERM INSULIN REQUIREMENT AFTER LIVER-TRANSPLANTATION WITH FK-506 IN AMERICAN VETERANS TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 677-678	4	16	7	11
1360	1360 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al. USE OF PROGRAF (FK-506) AS RESCUE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 679-688	4	29	5	9
#	Date / Author / Journal	LCS	GCS	LCR	CR
1361	1361 FUKUZAKI T, GOTOH M, MONDEN M, DONO K, WADA H, et al. INDUCTION OF UNRESPONSIVENESS TO ISLET ALLOGRAFT BY PREOPERATIVE DONOR SPLEEN-CELL INJECTION AND FK-506 TREATMENT TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 975-975	0	0	2	7
1362	1362 MANDEL TE FUTURE-DIRECTIONS IN TRANSPLANTATION MEDICAL JOURNAL OF AUSTRALIA. 1993 FEB 15; 158 (4): 269-273	0	2	2	55
1363	1363 CHANDLER C, PASSARO E TRANSPLANT REJECTION - MECHANISMS AND TREATMENT ARCHIVES OF SURGERY. 1993 MAR; 128 (3): 279-283	0	28	3	54
1364	1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al. SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375	3	12	6	32
1365	1365 STARZL TE, TODO S, Tzakis AG, Fung JJ THE TRANSPLANTATION OF GASTROINTESTINAL ORGANS GASTROENTEROLOGY. 1993 MAR; 104 (3): 673-679	1	13	11	39
1366	1366 SHORROCK C, NEUBERGER J THE CHANGING FACE OF LIVER-TRANSPLANTATION GUT. 1993 MAR; 34 (3): 295-298	0	3	6	52
1367	1367 SAKR MF, MCCLAIN CJ, GAVALER JS, ZETTI GM, STARZL TE, et al. FK-506 PRETREATMENT IS ASSOCIATED WITH REDUCED LEVELS OF TUMOR- NECROSIS-FACTOR AND INTERLEUKIN-6 FOLLOWING HEPATIC ISCHEMIA- REPERFUSION JOURNAL OF HEPATOLOGY. 1993 MAR; 17 (3): 301-307	8	41	2	58
1368	1368 HAYES JM THE IMMUNOBIOLOGY AND CLINICAL USE OF CURRENT IMMUNOSUPPRESSIVE THERAPY FOR RENAL-TRANSPLANTATION JOURNAL OF UROLOGY. 1993 MAR; 149 (3): 437-448	1	17	27	241
1369	1369 TAKEGUCHI N, ICHIMURA K, KOIKE M, MATSUI W, KASHIWAGURA T, et al. INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE TRANSPLANTATION. 1993 MAR; 55 (3): 646-650	0	46	2	30
1370	1370 VALDIVIA LA, DEMETRIS AJ, FUNG JJ, CELLI S, MURASE N, et al. SUCCESSFUL HAMSTER-TO-RAT LIVER XENOTRANSPLANTATION UNDER FK506 IMMUNOSUPPRESSION INDUCES UNRESPONSIVENESS TO HAMSTER HEART AND SKIN TRANSPLANTATION. 1993 MAR; 55 (3): 659-661	6	22	2	11
#	Date / Author / Journal	LCS	GCS	LCR	CR
1371	1371 STARZL TE, DEMETRIS AJ, TRUCCO M, RICORDI C, ILDSTAD S, et al. CHIMERISM AFTER LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE- DISEASE AND TYPE-1 GAUCHERS-DISEASE NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 745-749	97	162	2	29
1372	1372 GOOD RA MIXED CHIMERISM AND IMMUNOLOGICAL-TOLERANCE NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 801-802	5	8	2	10
1373	1373 HRUBAN RH, LONG PP, PERLMAN EJ, HUTCHINS GM, BAUMGARTNER WA, et al. FLUORESCENCE INSITU HYBRIDIZATION FOR THE Y-CHROMOSOME CAN BE USED TO DETECT CELLS OF RECIPIENT ORIGIN IN ALLOGRAFTED HEARTS FOLLOWING CARDIAC TRANSPLANTATION AMERICAN JOURNAL OF PATHOLOGY. 1993 APR; 142 (4): 975-980	9	100	3	37
1374	1374 UEKI M, YASUNAMI Y, INA K, RYU S, FUNAKOSHI A, et al. DIABETOGENIC EFFECTS OF FK506 ON RENAL SUBCAPSULAR ISLET ISOGRAFTS IN RAT DIABETES RESEARCH AND CLINICAL PRACTICE. 1993 APR; 20 (1): 11-19	2	15	6	17
1375	1375 DOI R, INOUE K, CHOWDHURY P, KAJI H, RAYFORD PL STRUCTURAL AND FUNCTIONAL-CHANGES OF EXOCRINE PANCREAS INDUCED BY FK506 IN RATS GASTROENTEROLOGY. 1993 APR; 104 (4): 1153-1164	0	11	5	44
1376	1376 KOUTOUBY R, ZUCKER C, ZUCKER K, BURKE G, NERY J, et al. MOLECULAR MONITORING OF THE IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS BY USING A QUANTITATIVE POLYMERASE CHAIN-REACTION HUMAN IMMUNOLOGY. 1993 APR; 36 (4): 227-234	0	13	1	18
1377	1377 THOMSON AW, CARROLL PB, MCCAULEY J, WOO J, ABUELMAGD K, et al. FK-506 - A NOVEL IMMUNOSUPPRESSANT FOR TREATMENT OF AUTOIMMUNE-DISEASE - RATIONALE AND PRELIMINARY CLINICAL-EXPERIENCE AT THE UNIVERSITY-OF- PITTSBURGH SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 1993 APR; 14 (4): 323-344	9	44	7	56
1378	1378 MURASE N, STARZL TE, DEMETRIS AJ, VALDIVIA L, TANABE M, et al. HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS TRANSPLANTATION. 1993 APR; 55 (4): 701-708	17	128	7	34
1379	1379 KIKUCHI N, YAMAGUCHI Y, GOTO M, MAKINO Y, TAKATA N, et al. INFLUENCE OF CYCLOSPORINE ON LIVER-REGENERATION AFTER ORTHOTOPIC REDUCED-SIZE HEPATIC TRANSPLANTATION IN THE RAT TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1909-1911	0	0	2	7
1380	1380 WOODLE ES, SO S, JENDRISAK MD, PERDRIZET GA, WHITE HM, et al. RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1988-1989	0	0	2	3
#	Date / Author / Journal	LCS	GCS	LCR	CR
1381	1381 WOODLE ES, PERDRIZET GA, SO S, JENDRISAK MD, WHITE HM, et al. FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1990-1991	2	6	3	5
1382	1382 ANAISE D, RAPAPORT FT USE OF NON HEART-BEATING CADAVER DONORS IN CLINICAL ORGAN-TRANSPLANTATION - LOGISTICS, ETHICS, AND LEGAL CONSIDERATIONS TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 2153-2155	0	16	1	35
1383	1383 BAUMANN K, EDMUNDS AJF, GRASSBERGER MA, SCHULZ G, SCHULER W, et al. MODIFICATION OF THE IMMUNOSUPPRESSANT ASCOMYCIN (21-ETHYL-FK506) AT THE C19-C20 DOUBLE-BOND TETRAHEDRON LETTERS. 1993 APR 2; 34 (14): 2295-2298	0	6	4	20
1384	1384 WINKLER M, SCHULZE F, JOST U, RINGE B, PICHLMAYR R ANEMIA ASSOCIATED WITH FK-506 IMMUNOSUPPRESSION LANCET. 1993 APR 17; 341 (8851): 1035-1036	1	12	1	3
1385	1385 TRZEPACZ PT, DIMARTINI A, TRINGALI R PSYCHOPHARMACOLOGICAL ISSUES IN ORGAN-TRANSPLANTATION .1. PHARMACOKINETICS IN ORGAN FAILURE AND PSYCHIATRIC ASPECTS OF IMMUNOSUPPRESSANTS AND ANTIINFECTIOUS AGENTS PSYCHOSOMATICS. 1993 MAY-JUN; 34 (3): 199-207	0	20	4	89
1386	1386 BACKMAN L, GIBBS J, LEVY M, MCMILLAN R, HOLMAN M, et al. CAUSES OF LATE GRAFT LOSS AFTER LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 MAY; 55 (5): 1078-1082	2	51	4	16
1387	1387 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al. DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION TRENDS IN PHARMACOLOGICAL SCIENCES. 1993 MAY; 14 (5): 217-223	6	9	10	52
1388	1388 MATHEWS KA, GALLIVAN GJ, MALLARD BA CLINICAL, BIOCHEMICAL, AND HEMATOLOGIC EVALUATION OF NORMAL DOGS AFTER ADMINISTRATION OF RABBIT ANTI-DOG THYMOCYTE SERUM VETERINARY SURGERY. 1993 MAY-JUN; 22 (3): 213-220	0	5	3	39
1389	1389 FAHR A CYCLOSPORINE CLINICAL PHARMACOKINETICS CLINICAL PHARMACOKINETICS. 1993 JUN; 24 (6): 472-495	4	224	8	175
1390	1390 LOWES JR, HUBSCHER SG, NEUBERGER JM CHRONIC REJECTION OF THE LIVER ALLOGRAFT GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1993 JUN; 22 (2): 401-420	7	33	2	82
#	Date / Author / Journal	LCS	GCS	LCR	CR
1391	1391 STARZL TE, DEMETRIS AJ, TRUCCO M, MURASE N, RICORDI C, et al. CELL-MIGRATION AND CHIMERISM AFTER WHOLE-ORGAN TRANSPLANTATION - THE BASIS OF GRAFT ACCEPTANCE HEPATOLOGY. 1993 JUN; 17 (6): 1127-1152	561	561	20	155
1392	1392 STEINMAN RM, INABA K, AUSTYN JM DONOR-DERIVED CHIMERISM IN RECIPIENTS OF ORGAN TRANSPLANTS HEPATOLOGY. 1993 JUN; 17 (6): 1153-1156	22	24	1	30
1393	1393 GIANELLO P, FISHBEIN JM, SACHS DH TOLERANCE TO PRIMARILY VASCULARIZED ALLOGRAFTS IN MINIATURE SWINE IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 19-44	4	44	2	91
1394	1394 GROSSMAN Z CELLULAR TOLERANCE AS A DYNAMIC STATE OF THE ADAPTABLE LYMPHOCYTE IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 45-73	0	38	1	79
1395	1395 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al. DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 217-223, 1993) IMMUNOLOGY TODAY. 1993 JUN; 14 (6): 326-332	127	210	11	53
1396	1396 WARTY V, ZUCKERMAN S, VENKATARAMANAN R, LEVER J, Fung JJ, et al. FK506 MEASUREMENT - COMPARISON OF DIFFERENT ANALYTICAL METHODS THERAPEUTIC DRUG MONITORING. 1993 JUN; 15 (3): 204-208	8	19	3	13
1397	1397 STARZL TE, DEMETRIS AJ, TRUCCO M, ZEEVI A, RAMOS H, et al. CHIMERISM AND DONOR-SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION TRANSPLANTATION. 1993 JUN; 55 (6): 1272-1277	171	273	9	31
1398	1398 EVANS RW, MANNINEN DL, DONG FB, ASCHER NL, FRIST WH, et al. IMMUNOSUPPRESSIVE THERAPY AS A DETERMINANT OF TRANSPLANTATION OUTCOMES TRANSPLANTATION. 1993 JUN; 55 (6): 1297-1305	0	22	14	94
1399	1399 SMITH SD, JACKSON RJ, HANNAKAN CJ, WADOWSKY RM, Tzakis AG, et al. SELECTIVE DECONTAMINATION IN PEDIATRIC LIVER-TRANSPLANTS - A RANDOMIZED PROSPECTIVE-STUDY TRANSPLANTATION. 1993 JUN; 55 (6): 1306-1309	0	39	1	16
1400	1400 CHONG ASF, FINNEGAN A, JIANG XL, GEBEL H, SANKARY HN, et al. LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENT - THE MECHANISM OF INHIBITION OF T-CELL PROLIFERATION TRANSPLANTATION. 1993 JUN; 55 (6): 1361-1366	4	78	3	22

Date / Author / Journal

LCS

GCS

LCR

1992

1301

1301 KAHAN BD, GIBBONSSTUBBER S, TEJPAL N, CHOU TC

PROSPECTS FOR SYNERGISTIC IMMUNOSUPPRESSIVE DRUG-THERAPY IN THE COMING DECADE

TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1263-1265

1302

1302 ONA ET

EARLY PITFALLS IN RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1280-1282

1303

1303 YAMADA K, SUGISAKI Y, AKIMOTO M, YAMANAKA N

FK-506-INDUCED JUXTAGLOMERULAR APPARATUS HYPERPLASIA AND TUBULAR DAMAGE IN RAT KIDNEY-MORPHOLOGICAL AND BIOLOGIC ANALYSIS

TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1396-1398

1304

1304 FUKUSE T, HASEGAWA S, HIRAI T, HIRATA T, MURO K, et al.

OPTIMAL DOSE OF FK-506 IN CANINE LUNG ALLOTRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1399-1400

1305

1305 KENMOCHI T, ASANO T, SHIMADA H, OCHIAI T, ISONO K

CLINICAL AND EXPERIMENTAL STUDIES OF ACUTE-PANCREATITIS AFTER RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1992 AUG; 24 (4): 1578-1580

1306

1306 TODO S, Tzakis AG, ABUELMAGD K, REYES J, NAKAMURA K, et al.

INTESTINAL TRANSPLANTATION IN COMPOSITE VISCERAL GRAFTS OR ALONE

ANNALS OF SURGERY. 1992 SEP; 216 (3): 223-234

233

1307

1307 IWATSUKI S, STARZL TE

LIVER-TRANSPLANTATION IN THE MANAGEMENT OF BLEEDING ESOPHAGEAL-VARICES

BAILLIERES CLINICAL GASTROENTEROLOGY. 1992 SEP; 6 (3): 517-525

1308

1308 SATTLER M, GUENGERICH FP, YUN CH, CHRISTIANS U, SEWING KF

CYTOCHROME-P-450 3A ENZYMES ARE RESPONSIBLE FOR BIOTRANSFORMATION OF FK506 AND RAPAMYCIN IN MAN AND RAT

DRUG METABOLISM AND DISPOSITION. 1992 SEP-OCT; 20 (5): 753-761

299

1309

1309 MARSH JW, VEHE KL, WHITE HM

IMMUNOSUPPRESSANTS

GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1992 SEP; 21 (3): 679-693

105

1310

1310 EKSTRAND A, GROOP L, PETTERSSON E, GRONHAGENRISKA C, LAATIKAINEN L, et al.

METABOLIC CONTROL AND PROGRESSION OF COMPLICATIONS IN INSULIN-DEPENDENT DIABETIC-PATIENTS AFTER KIDNEY- TRANSPLANTATION

JOURNAL OF INTERNAL MEDICINE. 1992 SEP; 232 (3): 253-261

Date / Author / Journal

1311

LOW-DOSE STEROID-THERAPY IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS WITH WELL-FUNCTIONING GRAFTS

CANADIAN MEDICAL ASSOCIATION JOURNAL. 1992 SEP 1; 147 (5): 645-657

162

1312

1312 HOCKERSTEDT K

LIVER-TRANSPLANTATION - PRESENT RESULTS AND PROBLEMS

ANNALS OF MEDICINE. 1992 OCT; 24 (5): 325-328

1313

1313 REVILLARD JP

FROM ALLOGRAFTS TO XENOGRAFTS

BIOFUTUR. 1992 OCT; (116): 58-61

1314

1314 CHRISTIANS U, BRAUN F, SCHMIDT M, KOSIAN N, SCHIEBEL HM, et al.

SPECIFIC AND SENSITIVE MEASUREMENT OF FK506 AND ITS METABOLITES IN BLOOD AND URINE OF LIVER-GRAFT RECIPIENTS

CLINICAL CHEMISTRY. 1992 OCT; 38 (10): 2025-2032

1315

1315 LUO HY, CHEN HF, DALOZE P, WU JP

EFFECTS OF RAPAMYCIN ON HUMAN HLA-UNRESTRICTED CELL KILLING

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1992 OCT; 65 (1): 60-64

1316

1316 HANKE JH, NICHOLS LN, COON ME

FK506 AND RAPAMYCIN SELECTIVELY ENHANCE DEGRADATION OF IL-2 AND GM-CSF MESSENGER-RNA

LYMPHOKINE AND CYTOKINE RESEARCH. 1992 OCT; 11 (5): 221-231

1317

1317 ERICZON BG, WIJNEN RMH, KUBOTA K, KOOTSTRA G, GROTH CG

FK506-INDUCED IMPAIRMENT OF GLUCOSE-METABOLISM IN THE PRIMATE - STUDIES IN PANCREATIC TRANSPLANT RECIPIENTS AND IN NONTRANSPLANTED ANIMALS

TRANSPLANTATION. 1992 OCT; 54 (4): 615-620

1318

1318 BASRI N, AMAN H, ADIKU W, BARAQDAR A, BONATERO I, et al.

DIABETES-MELLITUS AFTER RENAL-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1992 OCT; 24 (5): 1780-1781

1319

1319 STARZL TE, DEMETRIS AJ, TRUCCO M, RAMOS H, ZEEVI A, et al.

SYSTEMIC CHIMERISM IN HUMAN FEMALE RECIPIENTS OF MALE LIVERS

LANCET. 1992 OCT 10; 340 (8824): 876-877

175

277

1320

1320 JAFFE IA

NEW APPROACHES TO THE MANAGEMENT OF RHEUMATOID-ARTHRITIS

JOURNAL OF RHEUMATOLOGY. 1992 NOV; 19: 2-8

Date / Author / Journal

LCS

GCS

LCR

1321

1321 BENIGNI A, MORIGI M, PERICO N, ZOJA C, AMUCHASTEGUI CS, et al.

THE ACUTE EFFECT OF FK506 AND CYCLOSPORINE ON ENDOTHELIAL-CELL FUNCTION AND RENAL VASCULAR-RESISTANCE

TRANSPLANTATION. 1992 NOV; 54 (5): 775-780

1322

1322 MOR E, GONWA TA, HUSBERG BS, GOLDSTEIN RM, KLINTMALM GB

LATE-ONSET ACUTE REJECTION IN ORTHOTOPIC LIVER-TRANSPLANTATION - ASSOCIATED RISK-FACTORS AND OUTCOME

TRANSPLANTATION. 1992 NOV; 54 (5): 821-824

1323

1323 HIRANO Y, HISATOMI A, OHARA K, NOGUCHI H

THE EFFECTS OF FK506 AND CYCLOSPORINE ON THE EXOCRINE FUNCTION OF THE RAT PANCREAS

TRANSPLANTATION. 1992 NOV; 54 (5): 883-887

1324

1324 BOWMAN H, LENNARD TWJ

IMMUNOSUPPRESSIVE DRUGS

BRITISH JOURNAL OF HOSPITAL MEDICINE. 1992 NOV 4; 48 (9): 570-&

1325

1325 RADZICKA A, ACHESON SA, WOLFENDEN R

CIS-TRANSISOMERIZATION AT PROLINE - DESOLVATION AND ITS CONSEQUENCES FOR PROTEIN FOLDING

BIOORGANIC CHEMISTRY. 1992 DEC; 20 (4): 382-386

1326

1326 DEPAULIS A, STELLATO C, CIRILLO R, CICCARELLI A, ORIENTE A, et al.

ANTIINFLAMMATORY EFFECT OF FK-506 ON HUMAN SKIN MAST-CELLS

JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1992 DEC; 99 (6): 723-728

1327

1327 ODELL JA, BRINK JG, ROBSON S, TERBLANCHE J, KAHN D

TRANSPLANTATION OF SOLID ORGANS IN SOUTH-AFRICA

SOUTH AFRICAN MEDICAL JOURNAL. 1992 DEC; 82 (6): 427-431

1328

1328 PROPPER DJ, WOO J, MACLEOD AM, CATTO GRD, THOMSON AW

THE EFFECTS OF RAPAMYCIN ON HUMORAL IMMUNITY INVIVO - SUPPRESSION OF PRIMARY RESPONSES BUT NOT OF ONGOING ALLOANTIBODY SYNTHESIS OR MEMORY RESPONSES

TRANSPLANTATION. 1992 DEC; 54 (6): 1058-1063

1329

1329 SOUZA ERM, BOIM MA, BERGAMASCHI C, VERSOLATO C, PESTANA JOM, et al.

ACUTE EFFECTS OF FK-506 ON GLOMERULAR HEMODYNAMICS

TRANSPLANTATION PROCEEDINGS. 1992 DEC; 24 (6): 3082-3082

1993

1330

1330 SCHULER W, CHRISTIANS U, SCHMIEDER P, SCHIEBEL HM, HOLZE I, et al.

STRUCTURAL INVESTIGATIONS OF 13-O-DEMETHYL-FK506 AND ITS ISOMERS GENERATED BY IN-VITRO METABOLISM OF FK506 USING HUMAN-LIVER MICROSOMES

HELVETICA CHIMICA ACTA. 1993; 76 (6): 2288-2302

Date / Author / Journal

LCS

GCS

LCR

1331

1331 THOMSON AW, PROPPER DJ, WOO J, WHITING PH, MILTON JI, et al.

COMPARATIVE EFFECTS OF RAPAMYCIN-FK-506 AND CYCLOSPORINE ON ANTIBODY-PRODUCTION, LYMPHOCYTE POPULATIONS AND IMMUNOGLOBULIN ISOTYPE SWITCHING IN THE RAT

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY. 1993; 15 (4): 355-369

1332

1332 TAKAHARA S

EFFICACY OF FK506 IN RENAL-TRANSPLANTATION

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 235-244

1333

1333 LEMSTER B, RILO HR, CARROLL PB, NALESNIK MA, THOMSON AW

FK-506 INHIBITS CYTOKINE GENE AND ADHESION MOLECULE EXPRESSION IN PSORIATIC SKIN-LESIONS

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 250-256

1334

1334 TAMURA K, WOO J, MURASE N, NALESNIK M, THOMSON AW

INHIBITORY EFFECT OF FK-506 ON AUTOIMMUNE THYROID-DISEASE IN THE PVG RAT

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 257-262

1335

1335 OCHIAI T, GUNJI Y, NAGATA M, ISONO K

COMBINATION OF IMMUNOSUPPRESSIVE DRUGS FOR ORGAN-TRANSPLANTATION

IMMUNOSUPPRESSIVE AND ANTIINFLAMMATORY DRUGS. 1993; 696: 270-280

1336

1336 OLAUSSON M, WRAMNER L, KJELLSON B, MJORNSTEDT L, SODERSTROM T

ALTERATION IN T-CELL SUBSET PHENOTYPES AS CELL MARKERS FOR REJECTION OR LONG-TERM ALLOGRAFT ACCEPTANCE IN ALLOGRAFTED RATS TREATED WITH ANTITHYMOCYTE GLOBULIN

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 1993; 101 (4): 431-436

1337

1337 CHRISTIANS U, SEWING KF

CYCLOSPORINE METABOLISM IN TRANSPLANT PATIENTS

PHARMACOLOGY & THERAPEUTICS. 1993; 57 (2-3): 291-345

114

331

1338

1338 JIANG H, YAMAMOTO S, NISHIKAWA K, KATO R

ANTI-TUMOR-PROMOTING ACTION OF FK506, A POTENT IMMUNOSUPPRESSIVE AGENT

CARCINOGENESIS. 1993 JAN; 14 (1): 67-71

1339

1339 HIRAI T, WADDELL TK, PUSKAS JD, WADA H, HITOMI S, et al.

PROLONGED LUNG ALLOGRAFT SURVIVAL WITH A SHORT COURSE OF FK-506

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1993 JAN; 105 (1): 1-8

1340

1340 ZENG YJ, RICORDI C, LENDOIRE J, CARROLL PB, ALEJANDRO R, et al.

THE EFFECT OF PREDNISONE ON PANCREATIC-ISLET AUTOGRAFTS IN DOGS

SURGERY. 1993 JAN; 113 (1): 98-102

Date / Author / Journal

LCS

GCS

LCR

1341

1341 WAKUGAMI T, ISLAM MR, HIGA S, MURAKAMI K, MIMURA G

EFFECT OF FK506 ON THE DEVELOPMENT OF DIABETES IN BB RATS IN COMPARISON WITH THAT OF CYCLOSPORINE

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE. 1993 JAN; 169 (1): 21-29

1342

1342 STARZL TE, Fung JJ, Tzakis AG, TODO S, DEMETRIS AJ, et al.

BABOON-TO-HUMAN LIVER-TRANSPLANTATION

LANCET. 1993 JAN 9; 341 (8837): 65-71

296

1343

1343 BRUSERUD O, PAWELEC G

CYCLOSPORINE-A AND FK506 SHOW SIMILAR IMMUNOSUPPRESSIVE EFFECTS ON LONG-TERM INVITRO T-CELL PROLIFERATION

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. 1993 FEB; 15 (2): 93-97

1344

1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al.

EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 FEB; 55 (2): 288-292

1345

1345 CERRA FB

USE OF GREENFIELD FILTERS IN RENAL-TRANSPLANT PATIENTS - ARE THEY SAFE

TRANSPLANTATION. 1993 FEB; 55 (2): 439-442

1346

1346 STARZL TE

CONVOCATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 1-2

1347

1347 STARZL TE

CELL-MIGRATION AND CHIMERISM - A UNIFYING CONCEPT IN TRANSPLANTATION - WITH PARTICULAR REFERENCE TO HLA MATCHING AND TOLERANCE INDUCTION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 8-12

1348

1348 STARZL TE

LIVER ALLOTRANSPLANTATION AND XENOTRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 15-17

1349

1349 RAPAPORT FT

ALTERNATIVE SOURCES OF CLINICALLY TRANSPLANTABLE VITAL ORGANS

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 42-44

1350

1350 SRIWATANAWONGSA V, DAVIES HS, BRONS IGM, ASPINALL R, THIRU S, et al.

CONTINUED PRESENCE OF DONOR LEUKOCYTES IN RECIPIENTS OF LIVER GRAFTS

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 371-372

Date / Author / Journal

LCS

GCS

LCR

1351

1351 MURASE N, DEMETRIS AJ, TANABE M, MIYAZAWA H, VALDIVIA LA, et al.

EFFECT OF FK-506 AND ANTIPROLIFERATIVE AGENTS FOR HEART AND LIVER XENOTRANSPLANTATION FROM HAMSTER TO RAT

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 425-426

1352

1352 STARZL TE, MURASE N, DEMETRIS AJ, GIORDA R, VALDIVIA L, et al.

DRUG DEVELOPMENT AND TESTING IN RELATION TO CELL-MIGRATION AND CHIMERISM

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 469-472

1353

1353 LANG P, BIERLING P, BUISSON C, FRUCHAUD G, BUSSON M, et al.

INFLUENCE OF POSTTRANSPLANTATION BLOOD-TRANSFUSION ON KIDNEY ALLOGRAFT SURVIVAL - A ONE-CENTER, DOUBLE- BLIND, PROSPECTIVE, RANDOMIZED STUDY COMPARING CRYOPRESERVED AND FRESH RED-BLOOD-CELL CONCENTRATES

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 616-618

1354

1354 GIBBS JF, HUSBERG BS, KLINTMALM GB, BACKMAN L, LEVY M, et al.

OUTCOME ANALYSIS OF FK-506 THERAPY FOR ACUTE AND CHRONIC REJECTION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 622-623

1355

1355 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al.

USE OF FK-506 FOR THE PREVENTION OF RECURRENT ALLOGRAFT-REJECTION AFTER SUCCESSFUL CONVERSION FROM CYCLOSPORINE FOR REFRACTORY REJECTION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 635-637

1356

1356 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al.

PROGNOSTIC FACTORS FOR SUCCESSFUL CONVERSION FROM CYCLOSPORINE TO FK-506 - BASED IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 641-643

1357

1357 LANE BC, MILLER LN, KAWAI M, OR YS, WIEDEMAN P, et al.

EVALUATION OF CALCINEURIN ROLE IN THE IMMUNOSUPPRESSIVE ACTIVITY OF FK-506, RELATED MACROLACTAMS, AND CYCLOSPORINE

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 644-646

1358

1358 KUROKI H, BEAN MA, IKUTA Y, AKIYAMA M, BURGESS EM

EFFECT OF FK-506 AND DONOR-SPECIFIC BLOOD-TRANSFUSION ON THE RAT COMPOSITE TISSUE LIMB ALLOGRAFT AND THE MECHANISM OF LONG-TERM GRAFT-SURVIVAL

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 658-661

1359

1359 TABASCOMINGUILLAN J, MIELES L, CARROLL P, GAVALER J, VANTHIEL DH, et al.

LONG-TERM INSULIN REQUIREMENT AFTER LIVER-TRANSPLANTATION WITH FK-506 IN AMERICAN VETERANS

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 677-678

1360

1360 KLINTMALM GBG, GOLDSTEIN R, GONWA T, WIESNER RH, KROM RAF, et al.

USE OF PROGRAF (FK-506) AS RESCUE THERAPY FOR REFRACTORY REJECTION AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 679-688

Date / Author / Journal

LCS

GCS

LCR

1361

1361 FUKUZAKI T, GOTOH M, MONDEN M, DONO K, WADA H, et al.

INDUCTION OF UNRESPONSIVENESS TO ISLET ALLOGRAFT BY PREOPERATIVE DONOR SPLEEN-CELL INJECTION AND FK-506 TREATMENT

TRANSPLANTATION PROCEEDINGS. 1993 FEB; 25 (1): 975-975

1362

1362 MANDEL TE

FUTURE-DIRECTIONS IN TRANSPLANTATION

MEDICAL JOURNAL OF AUSTRALIA. 1993 FEB 15; 158 (4): 269-273

1363

1363 CHANDLER C, PASSARO E

TRANSPLANT REJECTION - MECHANISMS AND TREATMENT

ARCHIVES OF SURGERY. 1993 MAR; 128 (3): 279-283

1364

1364 TAMURA K, WOO J, MURASE N, CARRIERI G, NALESNIK MA, et al.

SUPPRESSION OF AUTOIMMUNE THYROID-DISEASE BY FK-506 - INFLUENCE ON THYROID-INFILTRATING CELLS, ADHESION MOLECULE EXPRESSION AND ANTITHYROGLOBULIN ANTIBODY-PRODUCTION

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1993 MAR; 91 (3): 368-375

1365

1365 STARZL TE, TODO S, Tzakis AG, Fung JJ

THE TRANSPLANTATION OF GASTROINTESTINAL ORGANS

GASTROENTEROLOGY. 1993 MAR; 104 (3): 673-679

1366

1366 SHORROCK C, NEUBERGER J

THE CHANGING FACE OF LIVER-TRANSPLANTATION

GUT. 1993 MAR; 34 (3): 295-298

1367

1367 SAKR MF, MCCLAIN CJ, GAVALER JS, ZETTI GM, STARZL TE, et al.

FK-506 PRETREATMENT IS ASSOCIATED WITH REDUCED LEVELS OF TUMOR- NECROSIS-FACTOR AND INTERLEUKIN-6 FOLLOWING HEPATIC ISCHEMIA- REPERFUSION

JOURNAL OF HEPATOLOGY. 1993 MAR; 17 (3): 301-307

1368

1368 HAYES JM

THE IMMUNOBIOLOGY AND CLINICAL USE OF CURRENT IMMUNOSUPPRESSIVE THERAPY FOR RENAL-TRANSPLANTATION

JOURNAL OF UROLOGY. 1993 MAR; 149 (3): 437-448

241

1369

1369 TAKEGUCHI N, ICHIMURA K, KOIKE M, MATSUI W, KASHIWAGURA T, et al.

INHIBITION OF THE MULTIDRUG EFFLUX PUMP IN ISOLATED HEPATOCYTE COUPLETS BY IMMUNOSUPPRESSANTS FK506 AND CYCLOSPORINE

TRANSPLANTATION. 1993 MAR; 55 (3): 646-650

1370

1370 VALDIVIA LA, DEMETRIS AJ, FUNG JJ, CELLI S, MURASE N, et al.

SUCCESSFUL HAMSTER-TO-RAT LIVER XENOTRANSPLANTATION UNDER FK506 IMMUNOSUPPRESSION INDUCES UNRESPONSIVENESS TO HAMSTER HEART AND SKIN

TRANSPLANTATION. 1993 MAR; 55 (3): 659-661

Date / Author / Journal

LCS

GCS

LCR

1371

1371 STARZL TE, DEMETRIS AJ, TRUCCO M, RICORDI C, ILDSTAD S, et al.

CHIMERISM AFTER LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE- DISEASE AND TYPE-1 GAUCHERS-DISEASE

NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 745-749

162

1372

1372 GOOD RA

MIXED CHIMERISM AND IMMUNOLOGICAL-TOLERANCE

NEW ENGLAND JOURNAL OF MEDICINE. 1993 MAR 18; 328 (11): 801-802

1373

1373 HRUBAN RH, LONG PP, PERLMAN EJ, HUTCHINS GM, BAUMGARTNER WA, et al.

FLUORESCENCE INSITU HYBRIDIZATION FOR THE Y-CHROMOSOME CAN BE USED TO DETECT CELLS OF RECIPIENT ORIGIN IN ALLOGRAFTED HEARTS FOLLOWING CARDIAC TRANSPLANTATION

AMERICAN JOURNAL OF PATHOLOGY. 1993 APR; 142 (4): 975-980

100

1374

1374 UEKI M, YASUNAMI Y, INA K, RYU S, FUNAKOSHI A, et al.

DIABETOGENIC EFFECTS OF FK506 ON RENAL SUBCAPSULAR ISLET ISOGRAFTS IN RAT

DIABETES RESEARCH AND CLINICAL PRACTICE. 1993 APR; 20 (1): 11-19

1375

1375 DOI R, INOUE K, CHOWDHURY P, KAJI H, RAYFORD PL

STRUCTURAL AND FUNCTIONAL-CHANGES OF EXOCRINE PANCREAS INDUCED BY FK506 IN RATS

GASTROENTEROLOGY. 1993 APR; 104 (4): 1153-1164

1376

1376 KOUTOUBY R, ZUCKER C, ZUCKER K, BURKE G, NERY J, et al.

MOLECULAR MONITORING OF THE IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS BY USING A QUANTITATIVE POLYMERASE CHAIN-REACTION

HUMAN IMMUNOLOGY. 1993 APR; 36 (4): 227-234

1377

1377 THOMSON AW, CARROLL PB, MCCAULEY J, WOO J, ABUELMAGD K, et al.

FK-506 - A NOVEL IMMUNOSUPPRESSANT FOR TREATMENT OF AUTOIMMUNE-DISEASE - RATIONALE AND PRELIMINARY CLINICAL-EXPERIENCE AT THE UNIVERSITY-OF- PITTSBURGH

SPRINGER SEMINARS IN IMMUNOPATHOLOGY. 1993 APR; 14 (4): 323-344

1378

1378 MURASE N, STARZL TE, DEMETRIS AJ, VALDIVIA L, TANABE M, et al.

HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS

TRANSPLANTATION. 1993 APR; 55 (4): 701-708

128

1379

1379 KIKUCHI N, YAMAGUCHI Y, GOTO M, MAKINO Y, TAKATA N, et al.

INFLUENCE OF CYCLOSPORINE ON LIVER-REGENERATION AFTER ORTHOTOPIC REDUCED-SIZE HEPATIC TRANSPLANTATION IN THE RAT

TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1909-1911

1380

1380 WOODLE ES, SO S, JENDRISAK MD, PERDRIZET GA, WHITE HM, et al.

RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION

TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1988-1989

Date / Author / Journal

LCS

GCS

LCR

1381

1381 WOODLE ES, PERDRIZET GA, SO S, JENDRISAK MD, WHITE HM, et al.

FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY

TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 1990-1991

1382

1382 ANAISE D, RAPAPORT FT

USE OF NON HEART-BEATING CADAVER DONORS IN CLINICAL ORGAN-TRANSPLANTATION - LOGISTICS, ETHICS, AND LEGAL CONSIDERATIONS

TRANSPLANTATION PROCEEDINGS. 1993 APR; 25 (2): 2153-2155

1383

1383 BAUMANN K, EDMUNDS AJF, GRASSBERGER MA, SCHULZ G, SCHULER W, et al.

MODIFICATION OF THE IMMUNOSUPPRESSANT ASCOMYCIN (21-ETHYL-FK506) AT THE C19-C20 DOUBLE-BOND

TETRAHEDRON LETTERS. 1993 APR 2; 34 (14): 2295-2298

1384

1384 WINKLER M, SCHULZE F, JOST U, RINGE B, PICHLMAYR R

ANEMIA ASSOCIATED WITH FK-506 IMMUNOSUPPRESSION

LANCET. 1993 APR 17; 341 (8851): 1035-1036

1385

1385 TRZEPACZ PT, DIMARTINI A, TRINGALI R

PSYCHOPHARMACOLOGICAL ISSUES IN ORGAN-TRANSPLANTATION .1. PHARMACOKINETICS IN ORGAN FAILURE AND PSYCHIATRIC ASPECTS OF IMMUNOSUPPRESSANTS AND ANTIINFECTIOUS AGENTS

PSYCHOSOMATICS. 1993 MAY-JUN; 34 (3): 199-207

1386

1386 BACKMAN L, GIBBS J, LEVY M, MCMILLAN R, HOLMAN M, et al.

CAUSES OF LATE GRAFT LOSS AFTER LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 MAY; 55 (5): 1078-1082

1387

1387 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al.

DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION

TRENDS IN PHARMACOLOGICAL SCIENCES. 1993 MAY; 14 (5): 217-223

1388

1388 MATHEWS KA, GALLIVAN GJ, MALLARD BA

CLINICAL, BIOCHEMICAL, AND HEMATOLOGIC EVALUATION OF NORMAL DOGS AFTER ADMINISTRATION OF RABBIT ANTI-DOG THYMOCYTE SERUM

VETERINARY SURGERY. 1993 MAY-JUN; 22 (3): 213-220

1389

1389 FAHR A

CYCLOSPORINE CLINICAL PHARMACOKINETICS

CLINICAL PHARMACOKINETICS. 1993 JUN; 24 (6): 472-495

224

175

1390

1390 LOWES JR, HUBSCHER SG, NEUBERGER JM

CHRONIC REJECTION OF THE LIVER ALLOGRAFT

GASTROENTEROLOGY CLINICS OF NORTH AMERICA. 1993 JUN; 22 (2): 401-420

Date / Author / Journal

LCS

GCS

LCR

1391

1391 STARZL TE, DEMETRIS AJ, TRUCCO M, MURASE N, RICORDI C, et al.

CELL-MIGRATION AND CHIMERISM AFTER WHOLE-ORGAN TRANSPLANTATION - THE BASIS OF GRAFT ACCEPTANCE

HEPATOLOGY. 1993 JUN; 17 (6): 1127-1152

561

155

1392

1392 STEINMAN RM, INABA K, AUSTYN JM

DONOR-DERIVED CHIMERISM IN RECIPIENTS OF ORGAN TRANSPLANTS

HEPATOLOGY. 1993 JUN; 17 (6): 1153-1156

1393

1393 GIANELLO P, FISHBEIN JM, SACHS DH

TOLERANCE TO PRIMARILY VASCULARIZED ALLOGRAFTS IN MINIATURE SWINE

IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 19-44

1394

1394 GROSSMAN Z

CELLULAR TOLERANCE AS A DYNAMIC STATE OF THE ADAPTABLE LYMPHOCYTE

IMMUNOLOGICAL REVIEWS. 1993 JUN; 133: 45-73

1395

1395 STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, et al.

DONOR CELL CHIMERISM PERMITTED BY IMMUNOSUPPRESSIVE DRUGS - A NEW VIEW OF ORGAN-TRANSPLANTATION (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 217-223, 1993)

IMMUNOLOGY TODAY. 1993 JUN; 14 (6): 326-332

127

210

1396

1396 WARTY V, ZUCKERMAN S, VENKATARAMANAN R, LEVER J, Fung JJ, et al.

FK506 MEASUREMENT - COMPARISON OF DIFFERENT ANALYTICAL METHODS

THERAPEUTIC DRUG MONITORING. 1993 JUN; 15 (3): 204-208

1397

1397 STARZL TE, DEMETRIS AJ, TRUCCO M, ZEEVI A, RAMOS H, et al.

CHIMERISM AND DONOR-SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION

TRANSPLANTATION. 1993 JUN; 55 (6): 1272-1277

171

273

1398

1398 EVANS RW, MANNINEN DL, DONG FB, ASCHER NL, FRIST WH, et al.

IMMUNOSUPPRESSIVE THERAPY AS A DETERMINANT OF TRANSPLANTATION OUTCOMES

TRANSPLANTATION. 1993 JUN; 55 (6): 1297-1305

1399

1399 SMITH SD, JACKSON RJ, HANNAKAN CJ, WADOWSKY RM, Tzakis AG, et al.

SELECTIVE DECONTAMINATION IN PEDIATRIC LIVER-TRANSPLANTS - A RANDOMIZED PROSPECTIVE-STUDY

TRANSPLANTATION. 1993 JUN; 55 (6): 1306-1309

1400

1400 CHONG ASF, FINNEGAN A, JIANG XL, GEBEL H, SANKARY HN, et al.

LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENT - THE MECHANISM OF INHIBITION OF T-CELL PROLIFERATION

TRANSPLANTATION. 1993 JUN; 55 (6): 1361-1366

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records